Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Nocera, Inc. (NCRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.2900-0.0600 (-4.44%)
At close: 04:00PM EST
1.3400 +0.05 (+3.88%)
After hours: 05:02PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.3500
Open1.3400
Bid1.1200 x 1100
Ask1.3400 x 2200
Day's Range1.2900 - 1.3400
52 Week Range1.1100 - 5.4900
Volume7,959
Avg. Volume18,463
Market Cap11.634M
Beta (5Y Monthly)1.96
PE Ratio (TTM)N/A
EPS (TTM)-1.0970
Earnings DateAug 23, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NCRA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nocera, Inc.
    Analyst Report: Boston Scientific CorporationBoston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
Advertisement
Advertisement